FR115M - New sulfonamide usable in therapy. - Google Patents

New sulfonamide usable in therapy.

Info

Publication number
FR115M
FR115M FR835238A FR835238A FR115M FR 115 M FR115 M FR 115M FR 835238 A FR835238 A FR 835238A FR 835238 A FR835238 A FR 835238A FR 115 M FR115 M FR 115M
Authority
FR
France
Prior art keywords
usable
therapy
new sulfonamide
sulfonamide
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR835238A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application granted granted Critical
Publication of FR115M publication Critical patent/FR115M/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR835238A priority Critical patent/FR115M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/42Benzene-sulfonamido pyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR835238A 1958-03-14 1960-08-08 New sulfonamide usable in therapy. Active FR115M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835238A FR115M (en) 1958-03-14 1960-08-08 New sulfonamide usable in therapy.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH5704858A CH366545A (en) 1958-03-14 1958-03-14 Process for the preparation of new N-acyl-sulfonamides
FR787914 1959-02-27
FR835238A FR115M (en) 1958-03-14 1960-08-08 New sulfonamide usable in therapy.

Publications (1)

Publication Number Publication Date
FR115M true FR115M (en) 1960-01-09

Family

ID=4520879

Family Applications (1)

Application Number Title Priority Date Filing Date
FR835238A Active FR115M (en) 1958-03-14 1960-08-08 New sulfonamide usable in therapy.

Country Status (4)

Country Link
CH (1) CH366545A (en)
ES (1) ES247571A1 (en)
FR (1) FR115M (en)
SE (1) SE301476B (en)

Also Published As

Publication number Publication date
SE301476B (en) 1968-06-10
ES247571A1 (en) 1960-01-01
CH366545A (en) 1963-01-15

Similar Documents

Publication Publication Date Title
FR302M (en) New m-butoxy-phenoxy-ethylamine usable in therapy.
FR308M (en) New pyridyl-ethyl-guanidine usable in therapy.
FR115M (en) New sulfonamide usable in therapy.
FR164M (en) New hydrazine usable in therapy.
FR116M (en) New sulfonamide derivative usable in therapy.
FR1898M (en) New substance usable in therapy.
FR221M (en) New guanidine usable in therapy.
FR163M (en) New phenoxy-ethylamine usable in therapy.
BE581628A (en) Stretcher-twist.
FR353M (en) New quinoline usable in therapy.
FR349M (en) New 1,3-dihydroxy-2-nitro-tricos-4-yne usable in therapy.
FR350M (en) New antibiotic lankavamycin usable in therapy.
FR309M (en) New piperazino-ethyl-guanidine usable in therapy.
DK106453C (en) Endoradiosonde.
FR351M (en) New antibiotic lankavacidin usable in therapy.
BE596272A (en) New substance usable in therapy.
BE583856A (en) Opacifying agent usable in readiology.
FR1327304A (en) New electrolytic developer usable in photoconductography
FR1029M (en) New 17α-isobutyl-androstane-3β, 17β-diol usable in therapy.
FR117M (en) New biguanide that can be used in therapy.
ES63919Y (en) Piggy bank
FR1217838A (en) Piggy bank
FR3174M (en) New δ-3β17β-dihydroxy-7α17α-dimethyl-19-nor-androstene usable in therapy.
FR303M (en) New guanidine usable in therapy.
FR348M (en) New 3,5,6-substituted glucofuranoside usable in therapy.